Weston, MA, United States of America

Philip R Dormitzer

USPTO Granted Patents = 34 

 

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Emeryville, CA (US) (2019)
  • Cambridge, MA (US) (2014 - 2020)
  • Armonk, NY (US) (2018 - 2021)
  • Weston, MA (US) (2013 - 2023)
  • Nyack, NY (US) (2023 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: Philip R. Dormitzer: Pioneering Innovations in Immunology

Introduction

Philip R. Dormitzer, based in Weston, MA, is an accomplished inventor with a notable portfolio of 32 patents. His work primarily focuses on innovations in the field of immunology, particularly relating to viral proteins and their applications in vaccine development.

Latest Patents

Dormitzer's recent patents include significant advancements such as the invention concerning the human cytomegalovirus (CMV) glycoprotein B (gB) protein. This invention encompasses mutants of the wild-type CMV glycoprotein B, featuring at least two amino acid mutations. The invention aims to create stabilized mutants that present alternative conformations, enhancing their usability in therapeutic applications.

Another notable patent involves respiratory syncytial virus (RSV) F protein compositions. This invention relates to immunogenic compositions comprising RSV F protein and details methods for preparing ecto-domain polypeptides of the RSV F protein. The compositions are engineered to evoke an immune response and represent key advancements in combating viral infections.

Career Highlights

Throughout his career, Dormitzer has worked for prominent companies, including Seqirus UK Limited and Novartis AG. His contributions have significantly shaped the landscape of vaccine research and development, marking him as a leader in the biotechnology industry.

Collaborations

In his professional journey, Dormitzer has collaborated with esteemed colleagues such as Peter W. Mason and Pirada Suphaphiphat. These collaborations have fostered innovative approaches in addressing critical health challenges, particularly in designing effective immunological responses.

Conclusion

Philip R. Dormitzer exemplifies the spirit of innovation in the field of immunology. With his extensive patent portfolio and collaborative efforts, he continues to make impactful contributions that advance health science and technology. His work lays the groundwork for future developments in vaccine research and provides insights into combatting viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…